Patrick D. McGorry | Psychiatrist.com

Original Research

Diagnostic Stability 18 Months After Treatment Initiation for First-Episode Psychosis

Letter to the Editor

Dr McGorry and Colleagues Reply

Original Research

Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis: A Randomized, Placebo-Controlled Trial

Original Research

Family Outcomes From a Randomized Control Trial of Relapse Prevention Therapy in First-Episode Psychosis

Article

Impact of Severity of Substance Use Disorder on Symptomatic and Functional Outcome in Young Individuals With First-Episode Psychosis

Original Research

Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions

Original Research

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome

Review Article

Overview of Violence to Self and Others During the First Episode of Psychosis

Letter to the Editor

Recommended Haloperidol and Risperidone Doses in First-Episode Psychosis

Original Research

The EPPIC Follow-Up Study of First-Episode Psychosis: Longer-Term Clinical and Functional Outcome 7 Years After Index Admission

Original Research

Randomized Controlled Trial of Interventions for Young People at Ultra High Risk for Psychosis: 6-Month Analysis

Original Research

Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years

Original Research

Taurine for First-Episode Psychosis

When your 18- to 26-year-old patients respond poorly to the antipsychotic prescribed for their first episode of psychosis, what else can you try? In this RCT, taurine, which acts...

Original Research

A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients